Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
101 (47%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-01-09 | 2020-03-26 | 102917 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-01-17 | 2020-01-25 | 103561 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-01-30 | 103566 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-02-02 | 2023-02-09 | 183425 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194148 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194151 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-16 | 2023-10-03 | 195103 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-19 | 2023-07-21 | 195443 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2024-01-11 | 2024-02-01 | 215731 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2021-09-09 | 2022-03-26 | 145449 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155183 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86914 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86917 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86920 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2019-09-19 | 92157 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-19 | 2023-08-04 | 195621 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-26 | 2023-08-18 | 196476 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-07-20 | 2024-01-19 | 199398 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-07-27 | 2024-01-19 | 200290 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210437 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-METOPROLOL | 50MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119976 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253165 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240081 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253182 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253160 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |